Navigation Links
Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
Date:11/10/2008

Changes will result in over $80 million reduction in 2009 cash expenditures

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced a corporate restructuring that will reduce its San Diego workforce by approximately 25 percent, or 340 employees, and reduce anticipated 2009 cash expenditures by more than $80 million. The restructuring and workforce reduction are part of the Company's business plan to be cash flow positive by the end of 2010. The Company remains fully staffed to grow product revenue from BYETTA(R) (exenatide) injection and SYMLIN(R) (pramlintide acetate) injection and bring exenatide once weekly to market. Amylin's collaboration with Eli Lilly and Company on the global development and commercialization of exenatide is unaffected by the restructuring.

"We've made a difficult, but necessary, decision as a result of factors affecting our business," said Daniel M. Bradbury, president and chief executive officer at Amylin Pharmaceuticals, Inc. "Sales revenues have not met the expectations we had when we scaled up our organization. Today's actions will bring operating expenses more in line with revenue and enable us to continue to achieve our business goals of increasing sales of BYETTA and SYMLIN and bringing exenatide once weekly to market as quickly as possible."

Mr. Bradbury continued, "The restructuring and workforce reductions impact administration, operations, and research and development. We continue to work closely with our partner Lilly to enhance the effectiveness and efficiency of the commercial organization."

The Company's Ohio facility, where exenatide once weekly is manufactured, is unaffected by the restructuring. After the workforce reductio
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
2. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Webcast Third Quarter Results
5. Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
6. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
7. Amylin and Lilly Set Date and Time for Conference Call
8. Amylin Pharmaceuticals to Webcast Second Quarter Results
9. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
10. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
11. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 A new report by ... applications and geography) - Size, Share, Global Trends, Company ... Forecast, 2013 - 2020", suggests that the global surgical ... 2020 registering a CAGR of 11.1% from 2014 to ... the electro surgical devices in operative procedures by providing ...
(Date:7/29/2014)... 29, 2014  ImmunoClin Corporation (IMCL) is a ... of infectious diseases as well as nutraceuticals. The ... of pathologies like cardiovascular disease, Alzheimer,s disease and ... Corporation will complete the strategic relocation of its ... , a key center of North American healthcare ...
(Date:7/29/2014)... MD (PRWEB) July 29, 2014 ... a vaccine pioneer in the biotechnology industry, announced ... Newport Coast Securities, Inc. to explore financing opportunities ... LAMP-vax technology, a breakthrough vaccine platform with the ... market. The company exclusively licensed the well-established LAMP ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 ... biomass feedstock supply innovation and supply chain advancements, ... feedstock management systems, Energy Grange™ and Supply ASSURE™. ... R&D and in-the-field testing aimed at consolidating and ... benefits to landowners, farmers and feedstock end users. ...
Breaking Biology Technology:Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3Genera Energy Introduces Proprietary Feedstock Management Systems 2Genera Energy Introduces Proprietary Feedstock Management Systems 3Genera Energy Introduces Proprietary Feedstock Management Systems 4
... 2011   Medical devices group ... sales growth of 5%. In an interview with ... Q2 results and introduces his plans for a new Strategic ... on emerging markets.  Bohuon also announced plans to ...
... There is a new way to design computer chips ... of diamond. A team of electrical engineers at Vanderbilt ... create microelectronic devices out of thin films of nanodiamond. ... recently, logical gates, which are a key element in ...
... Aug. 4, 2011 Interleukin Genetics, Inc. (OTCQB: ... and Webcast on Friday, August 12 at 9:30 a.m. EDT ... access the live call, dial 877-324-1976 (domestic) or 631-291-4550 (international). ... be available on the Investors section of Interleukin Genetics, Inc.,s ...
Cached Biology Technology:Designing diamond circuits for extreme environments 2Designing diamond circuits for extreme environments 3Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results 2
(Date:7/29/2014)... University researchers have developed an easier method to ... the work involved in diagnosing diseases. , DNA ... a strong partnership that can be used in ... which tag proteins with DNA can ... detection and visualisation of biological material. The method ...
(Date:7/29/2014)... 2014 With thirty days to go and almost ... 2014 Conference are well underway. The event, a joint ... EMBO, and the French Society for Biochemistry and Molecular ... to Thursday, 4 September at the Palais des Congrs ... the largest meeting for the life sciences in Europe ...
(Date:7/29/2014)... bacteria and algae, propel themselves using whip-like appendages ... a millimetre long, function like tiny oars, helping ... cilia are found on the surfaces of many ... liquids over the cell. , Flagella and ... expel pathogens from our airways, they establish the ...
Breaking Biology News(10 mins):New method provides researchers with efficient tool for tagging proteins 2Counting down to FEBS-EMBO 2014 in Paris, France 2Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3
... in one setting might spell disaster in another. In cancer ... and divide without restraint, it,s a welcome message for the ... this cell in his or her body. Weizmann Institute scientists ... message that prompts unbridled cellular growth. The molecular message ...
... Foundation (IOF) has published the first issue of the ... Available online on the IOF website at http://www.iofbonehealth.org/sub-hubs/progress-in-osteoporosis ... expert and author Professor Ego Seeman of the University ... revised in terms of design and content, placing increased ...
... Inc., (OTCBB: PMBS) announced today that they will be ... Colorado between June 23- 26, 2012. ... a media blitz for LipiGesic® M, which has been ... to be a safe, highly effective, first-line therapy for ...
Cached Biology News:Kill the messenger 2PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDS's Marketplace 2012 Trade Convention 2PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDS's Marketplace 2012 Trade Convention 3
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Yersinia pestis...
C/EBPdelta Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Adenylate kinase isoenzyme 6...
Biology Products: